LAS VEGAS - Tuesday, 03. December 2024
Leading intelligent and luxury mobility provider uses AWS to power its intelligent driving platform, innovate new connected vehicle services, and expand globally
(BUSINESS WIRE)--At AWS re:Invent, Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced that Lotus Technology (“Lotus”, NASDAQ:LOT), a leading global intelligent and luxury mobility provider, has chosen AWS as its preferred cloud provider to help support its development of intelligent, luxury car experiences. The automaker will use AWS to implement its Vision80 Strategy, a plan to transform the company into a global luxury technology brand by 2028.
With more than 70 years of racing heritage and automotive leadership, Lotus offers market-leading standards in performance, design and engineering. Lotus is dedicated to delivering luxury electric vehicles, with a focus on developing next-generation electric and dig
...
Read more »
|
Dubai, United Arab Emirates -
From crisis communication to financial storytelling, Matrix PR sets new benchmarks in public relations
Dubai-based boutique agency, Matrix Public Relations, has once again solidified its position as a trailblazer in the GCC communications landscape by winning multiple accolades at the 2024 Middle East Public Relations Association (MEPRA) Awards.
The agency walked away with one of the most sought-after awards - the prestigious Small Agency of the Year title, highlighting its expertise in crafting impactful strategies that help businesses and brands in the region build meaningful connections with their audiences.
The agency team also scooped another three prestigious campaign-specific honors, further underscoring its creative capabilities and strategic expertise in impactful strategies that help businesses and brands in the region build meaningful connections with corporate, brand, and cr
...
Read more »
|
The emirate of Sharjah today concluded celebrations to mark the 53rd UAE Eid Al Etihad (Union Day), showcasing the country’s vibrant culture and development story. Festivities took place over 13 days, attracting over 250 thousand of UAE nationals, residents, and visitors from around the world, who enjoyed over 200 performances and activities across Sharjah, that included 8 locations around the Emirate of Sharjah, while highlighting the special features of each city around Sharjah. As the celebrations brought together the nation to celebrate together this special occasion, and highlighted the history and the tradition of the United Arab Emirates.
The celebrations included traditional
...
Read more »
|
Dubai, United Arab Emirates - Tuesday, 03. December 2024 AETOSWire Print
Honoring the standout achievements in PR and communications over the past year; the Middle East Public Relations Association (MEPRA) hosted its 16th award edition on November 28, 2024. Attended by over 550 guests, the event gathered 62 top agencies and professionals to contend for esteemed titles across 53 competitive categories, celebrating excellence and transformative impact in the industry.
Showcasing the finest achievements in the industry, the MEPRA Awards 2024 celebrated groundbreaking campaigns, agencies, and professionals who redefined excellence through innovation. With over 770 entries judged by an esteemed panel of 130 industry veterans, the awards spotlighted communication campaigns that excelled in concept, strategy, and impact.
Agencies that outshined the evening for scooping maximum awards had Memac O
...
Read more »
|
OSAKA, Japan & CAMBRIDGE, Mass. - Tuesday, 03. December 2024
− Elritercept is a late-stage, potentially best-in-class activin inhibitor designed to treat anemia associated with certain hematologic cancers, including myelodysplastic syndromes and myelofibrosis
− Takeda to receive exclusive global license in all territories outside of mainland China, Hong Kong and Macau
− Transaction builds upon Takeda’s legacy in the treatment of hematologic cancers and advances company’s global oncology strategy
(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that it has entered into an exclusive licensing agreement with Keros Therapeutics, Inc. (Nasdaq: KROS) to further develop, manufacture and commercialize elritercept worldwide outside of mainland China, Hong Kong and Macau.
Elritercept is a late-stage investigational activin inhibitor designed to treat anemia associated with certain hematologic cancers, includi
...
Read more »
| |